MONTVALE, N.J., March 29 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals
Corp. (Nasdaq: MEMY), a biopharmaceutical company, today announced that Jim
Sulat, President and Chief Executive Officer, will provide a company update at
the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals
Conference on Wednesday, April 5th, at 3:45 p.m. E.T., at the Millennium
Broadway Hotel in New York City.
Interested parties may access a live audio webcast of the presentation by
visiting the Investor Relations section of Memory Pharmaceuticals' website at
http://www.memorypharma.com. An archived version of the webcast will be
available at the same location through April 12, 2006.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on
developing innovative drugs for the treatment of debilitating CNS disorders
such as Alzheimer's disease, schizophrenia, depression, bipolar disorder,
vascular dementia, mild cognitive impairment, Parkinson's disease and memory
impairments associated with aging. For additional information, please visit
our website at http://www.memorypharma.com.
SOURCE Memory Pharmaceuticals Corp.
-0- 03/29/2006
/CONTACT: Jzaneen Lalani, Vice President, Legal Affairs, +1-201-802-7249;
Laura Perry Stern Investor Relations, Inc., +1-212-362-1200/
/Web site: http://www.memorypharma.com /
(MEMY)
CO: Memory Pharmaceuticals Corp.
ST: New Jersey
IN: BIO HEA MTC
SU: TDS CCA
DO
-- NYW115 --
0780 03/29/2006 12:03 EST http://www.prnewswire.com
